Tohoku Chemical
7446.TWholesale Trade
Filed as TOHOKU CHEMICAL CO.,LTD. (2022-08–2026-05)
Financials · Consolidated
| Fiscal year ended | 2025-09 | 2024-09 | 2023-09 | 2022-09 | 2021-09 | 2020-09 |
|---|---|---|---|---|---|---|
| Revenue | ¥34.4bn | ¥32.2bn | ¥35.1bn | ¥37.3bn | ¥36.2bn | ¥31.0bn |
| Operating income | ¥518m | ¥353m | ¥751m | ¥944m | ¥713m | — |
| Ordinary income | ¥595m | ¥408m | ¥808m | ¥1.0bn | ¥759m | ¥410m |
| Net income (owners) | ¥429m | ¥237m | ¥556m | ¥658m | ¥517m | ¥378m |
| Total assets | ¥18.4bn | ¥17.2bn | ¥18.9bn | ¥17.5bn | ¥16.1bn | ¥14.6bn |
| Net assets / equity | ¥8.0bn | ¥7.5bn | ¥7.3bn | ¥6.7bn | ¥6.3bn | ¥5.7bn |
| Operating cash flow | ¥150m | −¥1.0bn | ¥1.3bn | ¥886m | ¥322m | ¥441m |
| EPS (basic) | ¥475.93 | ¥263.54 | ¥617.29 | ¥728.76 | ¥564.91 | ¥404.57 |
From EDINET filings. Select any figure to open the report it came from. r = changed in a later filing (the report page shows the original). — = not reported in the filings structured so far.
Reports · 2
| Period | Form | Figures |
|---|---|---|
| 2025-10-01 → 2026-03-31 | Half-year | 69 figures · EDINET |
| 2024-10-01 → 2025-03-31 | Half-year | 69 figures · EDINET |
22 more reports are still being processed.
Segments · FY ended 2025-09
| Segment | External sales |
|---|---|
| Academia Life Science Sales Group | ¥2.4bn |
| Industry Sales Group | ¥17.9bn |
| Medical Sales Group | ¥14.1bn |
| Total | ¥34.4bn |
Segment names from EDINET member IDs; not mapped to a common taxonomy.